11 results
pharmacology dm2 medications diagnosis differential table management sglt2 summary aldosterone algorithm canagliflozin cardiovascular dapagliflozin disorders dpp4 gout hyperuricemia hypoaldosteronism inpatient
Cardiovascular and renal effects comparison between SGLT-2 inhibitors - Canagliflozin (Invokana) - Dapagliflozin (Farxiga) - Empagliflozin
renal effects comparison ... between SGLT-2 inhibitors ... (Farxiga) - Empagliflozin ... (Steglatro) #diabetes ... renal #SGLT2i #Inhibitors
SGLT2 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
gliflozin): • Empagliflozin ... loss (~2-3kg) • Empagliflozin ... • Euglycemic diabetic ... #Summary #DM2 #diabetes ... #endocrinology
Diabetes Medications Summary Table Insulin Lifestyle modifications Metformin Sulfonylureas GLP-1 receptor agonists - ↓ major adverse CV events TZDs DPP-4 inhibitors SGLT2 inhibitors -
Diabetes Medications ... events TZDs DPP-4 inhibitors ... SGLT2 inhibitors ... medications #table #comparison ... #management #endocrinology
Effects on body weight of various classes of type-2 diabetes medications. - Metformin - Weight Loss
weight of various classes ... of type-2 diabetes ... Loss + - SGLT-2 inhibitors ... Loss +++ - DPP-4 inhibitors ... weightloss #weightgain #comparison
SGLT2 inhibitors, also called gliflozins, are a class of medications that alter essential physiology of the
SGLT2 inhibitors ... that modulate sodium ... treatment of type II diabetes ... (Farxiga®) and empagliflozin ... , #empagliflozin
Diabetes Mellitus Type 2 Inpatient Medication Guide Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Medication Guide Classes ... Sulfonylurea, TZD, DPP-4 inhibitor ... α-glucosidase inhibitor ... #pharmacology #comparison ... #table #endocrinology
SGLT2 Inhibitors SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
SGLT2 Inhibitors ... class of anti-diabetic ... kidney), which causes ... Medications #DM2 #Diabetes ... #Endocrinology
DPP-4 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
DPP-4 Inhibitors ... Mechanisms of Action: Inhibits ... not definitively cause ... #Summary #DM2 #diabetes ... #endocrinology
Etiologies of Hypoaldosteronism Hyporeninemic Hypoaldosteronism (Low Renin, Low Aldosterone) - Diabetic Nephropathy - NSAIDs Non-Hyporeninemic Hypoaldosteronism (Normal
Aldosterone) - Diabetic ... Aldosterone) - ACE Inhibitors ... #Aldosterone #Comparison ... #Table #Causes
Hyperuricemia - Differential Diagnosis Algorithm Primary - Over-production • Increased turnover of nucleotides Primary
Hyperparathyroidism • Diabetic ... drugs • ACE inhibitors ... Diagnosis #Algorithm #endocrinology ... #causes
No results found for "Morulae empagliflozin ddimer diabetes inhibitors endocrinology causes comparison"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Morulae #empagliflozin #ddimer #diabetes #inhibitors #endocrinology #causes #comparison